Erythritol doesn’t directly trigger blood clots on its own, but growing evidence suggests it makes clotting more likely by lowering the threshold at which your platelets activate. A 2023 study published in Nature Medicine found that people with the highest blood levels of erythritol were about twice as likely to experience a heart attack, stroke, or cardiovascular death over three years compared to those with the lowest levels. That finding, combined with lab and animal data showing erythritol enhances platelet reactivity, has raised serious questions about a sweetener long considered one of the safest sugar alternatives.
What the Research Actually Found
The concern traces back to a large study that initially screened blood from more than 1,000 people, looking for compounds whose levels correlated with future heart attacks and strokes. Erythritol emerged as a strong signal. The researchers then confirmed the association in two additional groups totaling nearly 3,000 people in the U.S. and Europe. Across all cohorts, those in the top 25% of blood erythritol levels faced roughly double the risk of major cardiovascular events over three years of follow-up compared to those in the bottom 25%.
The study didn’t stop at correlation. In lab experiments using human platelets (the blood cells responsible for clotting), erythritol treatment caused a dose-dependent increase in markers of platelet activation: more surface expression of P-selectin and activation of a key receptor involved in clot formation. When researchers tested human blood under conditions mimicking the shear forces inside blood vessels, erythritol significantly increased clot formation in a dose-dependent manner.
How Erythritol Affects Clotting
Erythritol doesn’t flip a switch that makes clots form out of nowhere. Instead, it makes platelets more sensitive to the signals that normally trigger clotting. Think of it as turning down the volume needed for an alarm to go off. In the presence of erythritol, platelets respond more aggressively to low-level activation signals they might otherwise ignore. Specifically, erythritol boosts calcium levels inside platelets when those cells encounter clotting triggers, making them stickier and more likely to clump together.
This matters most for people who already have risk factors for cardiovascular disease, such as narrowed arteries, high blood pressure, or diabetes, where low-level clotting signals are more common. In a healthy, smooth blood vessel there may be little consequence. In a vessel with plaque buildup, the extra platelet sensitivity could tip the balance toward a dangerous clot.
Blood Levels After a Typical Serving
One of the more striking details in the research is how dramatically blood levels spike after consuming erythritol. When volunteers drank a beverage containing 30 grams of erythritol (roughly the amount in a pint of erythritol-sweetened ice cream or a couple of keto baked goods), their plasma levels shot up nearly 1,000-fold within the first hour. Baseline blood levels of erythritol sit around 3 to 4 micromoles per liter. After a 30-gram dose, levels peaked at roughly 5 to 8 millimoles per liter within 30 minutes to two hours.
Unlike many substances that clear the body quickly, erythritol lingers. Blood concentrations can remain elevated above baseline for more than two days. Your body doesn’t break erythritol down; about 80 to 90% is excreted unchanged in urine over 24 to 48 hours. That prolonged elevation means the window during which platelets are exposed to high erythritol levels is surprisingly long after each serving.
The Reverse Causation Problem
A major criticism of the cardiovascular findings is that the relationship may run in the opposite direction. Your body naturally produces erythritol from glucose through a metabolic pathway called the pentose phosphate pathway. The liver, kidneys, and even red blood cells contribute to this endogenous production. People with obesity, insulin resistance, or poorly controlled blood sugar tend to produce more erythritol internally because their cells are processing excess glucose.
This creates a chicken-and-egg problem. Elevated blood erythritol has been independently linked to future weight gain around the midsection, type 2 diabetes, and diabetes-related kidney and eye damage. So when researchers find that high erythritol levels predict heart attacks, it’s possible those levels are simply a marker of metabolic dysfunction rather than a cause of cardiovascular harm. The people with the highest erythritol levels may have been at elevated risk because of the same metabolic conditions driving their erythritol production.
That said, the platelet experiments partially address this critique. The lab data show a direct, dose-dependent biological effect of erythritol on clot formation, which is harder to explain away as mere correlation. The picture that’s emerging is likely a combination: endogenous erythritol signals underlying metabolic problems, while dietary erythritol on top of that may amplify clotting risk.
Xylitol Shows Similar Effects
Erythritol isn’t the only sugar alcohol under scrutiny. Xylitol, another popular sweetener found in sugar-free gum and candies, shows aligned effects on platelet reactivity and clotting potential. After ingestion of either sweetener, blood levels rise 100- to 1,000-fold and remain elevated for hours, though the timeline differs. Xylitol levels stay above baseline for four to six hours or more, while erythritol persists for over two days.
Researchers have cautioned against assuming all sugar alcohols behave the same way, since each has a distinct molecular structure and metabolic profile. But the fact that both erythritol and xylitol independently enhance platelet responsiveness at physiological concentrations suggests this may be a broader concern with certain sugar alcohols rather than a quirk of one molecule.
Where Regulators Stand
Erythritol still holds Generally Recognized as Safe (GRAS) status with the FDA. However, the FDA has reviewed the Witkowski study and its methodology without making formal changes to erythritol’s status so far.
In Europe, the European Food Safety Authority is in the middle of a broader reassessment of erythritol as part of a systematic re-evaluation of food additives approved before 2009. EFSA recently set an acceptable daily intake of 0.5 grams per kilogram of body weight per day. For a 150-pound person, that works out to about 34 grams daily. Notably, EFSA found that both short-term and long-term erythritol exposure across all population groups currently exceeds this newly set limit, meaning many regular consumers are already above what EFSA considers the safe threshold.
That ADI was set primarily to protect against the laxative effects of erythritol and potential downstream consequences like electrolyte imbalance. The cardiovascular concerns are newer and still being incorporated into regulatory thinking. For now, no agency has pulled erythritol from the market or issued formal warnings about clotting risk, but the regulatory landscape is clearly shifting toward greater caution.
What This Means in Practice
If you’re an otherwise healthy person who occasionally uses erythritol in coffee or buys a product sweetened with it once in a while, the current evidence doesn’t suggest an immediate emergency. The cardiovascular association was strongest among people who already had risk factors for heart disease, and the platelet effects are about lowering the activation threshold rather than spontaneously causing clots.
The concern is more pointed if you consume erythritol regularly in large amounts, particularly if you have existing cardiovascular risk factors, diabetes, or obesity. In that case, you’re potentially adding a dietary source of erythritol on top of already elevated endogenous production, with blood levels staying high for days between servings. If you’re using erythritol as a primary sugar replacement in baking, beverages, and packaged foods, your cumulative daily intake could easily exceed the levels used in the studies showing platelet effects.
Other sweetener options exist, though each comes with its own trade-offs. Monk fruit extract and stevia are not sugar alcohols and haven’t shown similar platelet effects, though they lack the bulk and baking properties that make erythritol popular. Allulose is a low-calorie sugar that behaves more like erythritol in recipes but hasn’t been studied for clotting effects to the same degree.